Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 427 | 411 | 381 | 359 | 231 |
| Gross Profit | 427 | 411 | 381 | 359 | 231 |
| Operating Expenses | 1,341 | 949 | 783 | 616 | 387 |
| Operating Income | -914 | -539 | -402 | -257 | -156 |
| Interest Expense | 165 | 127 | 77 | 86 | 58 |
| Other Income | 2 | 3 | 3 | 17 | 0 |
| Pre-tax Income | -1,077 | -663 | -476 | -327 | -214 |
| Net Income Continuous | -1,077 | -663 | -476 | -327 | -214 |
| Net Income | $-1,077 | $-663 | $-476 | $-327 | $-214 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.02 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.03 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.03 | -0.02 | -0.01 | -0.01 |
| EBITDA(a) | $-891 | $-539 | $-350 | $-469 | $-149 |